MDMA Assisted Therapy Approval And Commercialization Projected Within Calendar 2024 Timeline Jun 22, 2023
Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study Jun 15, 2023
Numinus CEO Outlines MDMA Assisted-Therapy Strategy; Believes MAPS Phase 3 Data Coming Soon May 25, 2023
Australian Health Authority To Allow Psilocybin And MDMA Assisted Therapy For Depression, PTSD Feb 3, 2023
MAPS Executive Director Predicts MDMA Assisted Therapy Will Be Approved “Sometime Around April-May 2024” Jan 27, 2023
Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs Jul 19, 2022
Trade To Black Podcast: Numinus CEO Breaks Down B.C. Drug Possession News And Macro Psychedelic Market Jun 5, 2022